The appointment of Mass General Hospital obesity doctor Dr. Fatima Cody Stanford to the DGAC suggests that Biden's big government is collaborating with billion-dollar Big Pharma to shape the new obesity policy.
Conflicts of interest and potential corruption apparently exist in every corner of the Biden administration. As the 2025 Dietary Guidelines Advisory Committee (DGAC) begins its review of the Dietary Guidelines for Americans, a process that occurs every five years, Senator Chuck Grassley has disclosed that at least one committee member has significant ties to Big Pharma. In a March 17 letter to the Secretaries of the Department of Health and Human Services and the Department of Agriculture, Grassley highlighted the failure of both agencies to follow the recommendations from the National Academies of Science, Engineering, and Medicine—as requested by Congress—which explicitly call for public transparency for any known conflicts of interest.
Realizing a lucrative relati...